This supplement brings the main volume up-to-date. It includes significant cases and important recent developments that have occurred since publication of the main volume. This supplement includes an all-new Chapter 5A, which covers the use of evidence at trial. It examines, for example, the disputed criteria for admissibility of animal studies, the role of epidemiological evidence, and, going beyond the Frye criteria, the validity of specific test results. It also includes: How toxic tort litigation is impacted by the US Supreme Court's decisions in Boyle v. United Technologies (on implied preemption), Browning-Ferris Industries v. Kelko disposal (on punitive damages), and Beech Aircraft Co v. Rainey (on admissibility of government reports into evidence.; How to deal with substantive law developments in causes of action (civil RICO and market share theories), contribution between tortfeasors, medical surveillance funds, splitting claims for differing injuries from the same exposure, and new forms of hybrid settlements; the impace of procedural law developments in protective orders, use of sanctions for document nonproduction or destruction, and limitations on degrading personal depositions; new appendices provide examples showing how to oppose introduction of test results on grounds of lab error and the use of Expert Affidavits to bar test results from evidence, and present the complaint in State of Alaska v. Exxon, setting forth the causes of action in the Valdez oil spill disaster.
"synopsis" may belong to another edition of this title.